1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors
US8431592B2 · kind B2 · utility
12Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2011 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Jun 21, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of treatment of a proliferative disease which responds to inhibition of PI3-Kinase-related protein kinases, particularly the PI3-kinase, by administration of a novel organic compound of formula (I)to a human or animal requiring such treatment; and methods of treatment of inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease, by administration of such compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.